{"article_title": "Teva Buying Allergan Generics For $40.5B As Emerging Markets Boost Drug Spending", "article_keywords": ["emerging", "spending", "boost", "drug", "teva", "405b", "generics", "allergan", "markets", "buying"], "article_url": "http://www.forbes.com/sites/brucejapsen/2015/07/27/teva-buying-allergan-generics-for-40-5b-as-emerging-markets-boost-drug-spending/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Teva Pharmaceuticals (TEVA) said it has agreed to buy the generic drug business of Allergan (ACT) for $40.5 billion as emerging markets spend more on prescription drugs and more Americans gain health coverage and look for cheaper medicines. The deal will put Teva among the largest drug makers in the world [...]", "title": "Teva Buying Allergan Generics For $40.5B As Emerging Markets Boost Drug Spending", "url": "http://www.forbes.com/sites/brucejapsen/2015/07/27/teva-buying-allergan-generics-for-40-5b-as-emerging-markets-boost-drug-spending/", "image": "http://specials-images.forbesimg.com/imageserve/810c704ce72e449abd0e0dd9f211df1b/640x434.jpg?fit=scale", "updated_time": "2015-07-27T09:42:44-04:00", "type": "article"}, "twitter": {"description": "Teva Pharmaceuticals (TEVA) said it has agreed to buy the generic drug business of Allergan (ACT) for $40.5 billion as emerging markets spend more on prescription drugs and more Americans gain health coverage and look for cheaper medicines. The deal will put Teva among the largest drug makers in the world [...]", "creator": "@brucejapsen", "image": "http://specials-images.forbesimg.com/imageserve/810c704ce72e449abd0e0dd9f211df1b/640x434.jpg?fit=scale", "title": "Teva Buying Allergan Generics For $40.5B As Emerging Markets Boost Drug Spending", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2015-07-27", "published": "2015-07-27", "id": "blogAndPostId/blog/post/2125-12075"}, "news_keywords": "Business,Health,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "Teva Pharmaceuticals (TEVA) said it has agreed to buy the generic drug business of Allergan (ACT) for $40.5 billion as emerging markets spend more on prescription drugs and more Americans gain health coverage and look for cheaper medicines. The deal will put Teva among the largest drug makers in the world [...]"}, "_id": "\"57477af36914bd0286fce9c7\"", "article_summary": ""}